By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Metamark Genetics said yesterday that it has signed a research and licensing deal with Janssen Biotech on identifying and validating prognostic markers for cancer.

The firms intend to validate several of Metamark's Prognostic Determinants, which are genes that are believed to play a causal role in promoting tumor progression and metastases. Cambridge, Mass.-based Metamark makes MetamarkDx Prognostic Assays based on the Prognostic Determinants technology.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

May
15
Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Jun
20
Sponsored by
PerkinElmer

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.